Quantcast

Latest kidney cancer Stories

2012-12-29 05:00:59

Drs. William Y. Kim, of UNC, and James W. Mier, of Harvard, will each receive $250,000 grants to support innovative, translational kidney cancer research. Newport Beach, CA (PRWEB) December 28, 2012 The American Association for Cancer Research and Kure It are pleased to announce that William Y. Kim, M.D., and James W. Mier, M.D., will each receive a 2012 AACR-Kure It Grant for Kidney Cancer Research. Kim, assistant professor in the departments of medicine and genetics at the University of...

2012-11-13 12:03:33

Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that additional efforts are needed to prolong the survival of all patients with kidney cancer. Since the mid-1990s, black Americans have had a higher...

2012-10-17 11:58:32

Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology journal BJUI. The technique is primarily used to treat elderly patients who have complex health issues or decline surgery. But researchers from the Department of Urology at Churchill Hospital, Oxford, UK, say that the results of their study suggest that active...

2012-09-27 22:15:44

Researchers at the University of California, San Diego School of Medicine have found that recovery from an emerging, minimally invasive surgical technique called Laparo-Endoscopic Single-Site Surgery (LESS) was less painful for kidney cancer patients than traditional laparoscopic surgery. Study results were published in the September online edition of Urology. "In the largest prospective study of kidney cancer patients to date, the UC San Diego study showed less use of narcotic pain...

2012-08-01 10:42:19

A potentially powerful new approach to treating two lethal metastatic cancers – triple negative breast cancer and clear cell renal cell carcinoma, the most common form of kidney cancer – has been discovered by researchers at Mayo Clinic in Florida. In the online issue of Molecular Cancer Therapeutics, they report that two drugs, romidepsin and decitabine, work cooperatively to activate a potent tumor suppressor gene that is silenced in these cancers. Once the gene, secreted...

2012-06-11 21:34:21

Study shows a cancer therapy for renal cell carcinoma patients may be affected by another anti-cancer drug Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting explores treatment with a newly developed type of radioimmunotherapy used for treating a resistant form of kidney cancer. The agent is able to hone in on the disease, called clear cell renal carcinoma, and kill the cancer by delivering radiation directly to it. However, the study shows that its effectiveness...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.